Clinical Trial Update: Is the Nerve Growth Factor (NGF) a Useful Biomarker in Neurogenic Bladder Dysfunction After Spinal Cord Injury?

View source ↗

Summary

This clinical trial update discusses whether nerve growth factor (NGF) can serve as a biomarker for neurogenic bladder dysfunction after spinal cord injury.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neurogenic Detrusor Overactivity
• Neurogenic Lower Urinary Tract Dysfunction
• Spinal Cord Injury

Snippet

Sponsor: Swiss Paraplegic Research, Nottwil | Conditions: Spinal Cord Injury, Neurogenic Detrusor Overactivity | Status: COMPLETED